Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CFDA Approves New Once-Weekly Bydureon(R) to Improve Glycemic Control in Type-2 Diabetes Patients

prnasiaJanuary 05, 2018

Tag: Bydureon , 3SBio

PharmaSources Customer Service